Brazil finds disappointing 50.4% efficacy for China’s Sinovac vaccine
The Chinese vaccine Coronavac developed by Sinovac Biotech is 50.4% effective in preventing symptomatic infections according to a Brazilian study, just enough to pass the … Read more